INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$36.3M

$36,310,124

View Raw Line-Items
Live Feed: 2026-04-02
DNTH S
Dianthus Therapeutics, Inc. /DE/
Savitz Ryan • CFO
10b5-1 Sell
2026-03-31 $9,492,595Whalex8
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Soteropoulos Paula • Director
10b5-1 Sell
2026-03-31 $47,986
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Soteropoulos Paula • Director
10b5-1 Sell
2026-03-24 $2,153,712Large
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD • Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -36.3%
2026-03-12 $3,559,495Largex5
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Garcia Marino • CEO
10b5-1 SellΔOwn -18.2%
2026-03-12 $10,016,381MEGAx5
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat • Officer • EVP, Head of R&D
10b5-1 Sell
2026-03-12 $2,756,468Large
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Savitz Ryan • CFO
10b5-1 Sell
2025-12-04 $903,600
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat • Officer • EVP, Head of R&D
10b5-1 SellΔOwn -96.5%
2025-11-14 $4,158,442Large
View Form 4 →
DNTH S
Dianthus Therapeutics, Inc. /DE/
Randhawa Simrat • Officer • EVP, Head of R&D
10b5-1 SellΔOwn -28.6%
2025-11-13 $3,221,445Largex3
View Form 4 →